In cancer, this double inhibition has been associated with stronger effects on cancer cell death, as the expression of HSP70 is considered a protective mechanism of cells to survive treatments with HSP90 inhibitors {Kudryavtsev, 2017 #142}. Here, HSP90AB1 is linked to cancer.